Although we have not found any studies on the effect of selective Cdc42 inhibitors on obesity, it has been shown that systemic administration of a selective small molecule, the Cdc42 inhibitor CASIN, can significantly reduce inflammatory processes in the body and increase life expectancy [237]. The gene discussed is CDC42; the disease is obesity due to melanocortin 4 receptor deficiency.